While the exact mechanism underlying this effect is not fully understood, it has been proposed that reduced expression or activity of the neonatal Fc receptor (FcRn) in IBD patients impairs salvage of albumin and IgG, reflecting increased antibody CL. The gene discussed is ALB; the disease is inflammatory bowel disease.